Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Henry Schein Inc. | 14 | 1 | 1 | 0 | €64.84 | €80.03 | 23.419% |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.26 | €2.40 | 90.627% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.20 | - | - |
| Stoke Therapeutics Inc | 17 | 1 | 2 | 0 | €13.40 | €20.55 | 53.327% |
| Personalis Inc | 8 | 1 | 0 | 0 | €2.62 | €3.26 | 24.698% |
| Codexis Inc. | 6 | 1 | 0 | 0 | €3.36 | €8.36 | 148.638% |
| Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | €1.88 | €18.37 | 875.877% |
| Xencor Inc. | 14 | 1 | 0 | 0 | €19.60 | €31.70 | 61.717% |
| BeiGene Ltd ADR | 9 | 1 | 0 | 0 | €151.00 | €241.54 | 59.963% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | €45.40 | €48.75 | 7.378% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €167.74 | €200.06 | 19.266% |
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | €747.00 | €824.47 | 10.370% |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.72 | - | - |
| Esperion Therapeutis.Inc. | 17 | 1 | 3 | 0 | €2.27 | €8.55 | 275.792% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 4 | 0 | €993.60 | €1,034.6 | 4.130% |
| Alkermes plc | 16 | 2 | 2 | 0 | €25.80 | €35.01 | 35.710% |
| Inogen Inc. | 1 | 2 | 0 | 1 | €8.95 | €6.53 | -26.989% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 5 | 0 | €26.67 | €54.98 | 106.153% |
| Roche Holding AG ADR | 2 | 2 | 0 | 0 | €36.52 | €38.00 | 4.061% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.36 | €3.64 | 167.971% |
| Align Technology | 21 | 2 | 5 | 0 | €211.60 | €315.49 | 49.096% |
| TG Therapeutics Inc. | 21 | 2 | 0 | 0 | €18.07 | €28.06 | 55.310% |
| Incyte Corp. | 12 | 2 | 0 | 1 | €63.70 | €78.05 | 22.523% |
| Vertex Pharmaceuticals Inc. | 54 | 2 | 4 | 0 | €458.60 | €440.93 | -3.853% |
| Merck KGaA | 3 | 2 | 0 | 1 | €157.55 | €146.00 | -7.331% |